The TGFβ1 pathway is required for NFκB dependent gene expression in mouse keratinocytes

Cytokine

Volumn 64, Issue 3, 2013, Pages 652-659

  Hogan, Kelly A ^a,b   Ravindran, Anand ^a   Podolsky, Michael A ^a   Glick, Adam B ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Keratinocyte; NFkappaB; TGFbeta1; TNFalpha; UVB

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; I KAPPA B; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; PARTHENOLIDE; PROTEIN P50; SMAD2 PROTEIN; SMAD3 PROTEIN; SYNAPTOTAGMIN I; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING KINETICS; CYTOPLASM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; ENZYME SUBUNIT; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SUBUNIT; PROTEIN TRANSPORT; REPORTER GENE; REPRESSOR GENE; SIGNAL TRANSDUCTION; ULTRAVIOLET B RADIATION;

MUS;

ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5; CJUN N-TERMINAL KINASES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMSA; I KAPPA KINASEΑ; I KAPPAΒ; I KAPPAΒ SUPER REPRESSOR; IKKΑ; IKΒ; IKΒSR; JNK; KERATINOCYTE; NFKAPPAB; NUCLEAR FACTOR KAPPAB; SBE; SMAD BINDING ELEMENTS; TAK1; TGFBETA1; TGFΒ1; TGFΒ1 ACTIVATED KINASE 1; TNFALPHA; TNFΑ; TRANSFORMING GROWTH FACTOR-BETA 1; TUMOR NECROSIS FACTOR ALPHA; UVB;

ANIMALS; ANIMALS, NEWBORN; BENZAMIDES; CELLS, CULTURED; DIOXOLES; GENE EXPRESSION; IMMUNOBLOTTING; KERATINOCYTES; LUCIFERASES; MICE; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 84886948594     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.09.004     Document Type: Article

References (73)

1. Adachi M., Gazel A., Pintucci G., Shuck A., Shifteh S., Ginsburg D., et al. Specificity in stress response: epidermal keratinocytes exhibit specialized UV-responsive signal transduction pathways. DNA Cell Biol 2003, 22:665-677.
2. Sovak M.A., Arsura M., Zanieski G., Kavanagh K.T., Sonenshein G.E. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression. Cell Growth Differ 1999, 10:537-544.
3. Ogawa K., Chen F., Kuang C., Chen Y. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem J 2004, 381:413-422.
4. Kon A., Vindevoghel L., Kouba D.J., Fujimura Y., Uitto J., Mauviel A. Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression. Oncogene 1999, 18:1837-1844.
5. Lopez-Rovira T., Chalaux E., Rosa J.L., Bartrons R., Ventura F. Interaction and functional cooperation of NF-kappaB with Smads. Transcriptional regulation of the junB promoter. J Biol Chem 2000, 275:28937-28946.
6. Monteleone G., Mann J., Monteleone I., Vavassori P., Bremner R., Fantini M., et al. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation. J Biol Chem 2004, 279:3925-3932.
7. Bitzer M., von Gersdorff G., Liang D., Dominguez-Rosales A., Beg A.A., Rojkind M., et al. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappaB/RelA. Genes Dev 2000, 14:187-197.
8. Descargues P., Sil A.K., Sano Y., Korchynskyi O., Han G., Owens P., et al. IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci USA 2008, 105:2487-2492.
9. Cooper S.J., Bowden G.T. Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappaB (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. Curr Cancer Drug Targets 2007, 7:325-334.
10. Adhami V.M., Afaq F., Ahmad N. Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia 2003, 5:74-82.
11. Vicentini F.T., He T., Shao Y., Fonseca M.J., Verri W.A., Fisher G.J., et al. Quercetin inhibits UV irradiation-induced inflammatory cytokine production in primary human keratinocytes by suppressing NF-kappaB pathway. J Dermatol Sci 2011, 61:162-168.
12. Lee H.S., Kooshesh F., Sauder D.N., Kondo S. Modulation of TGF-beta 1 production from human keratinocytes by UVB. Exp Dermatol 1997, 6:105-110.
13. Han K.H., Choi H.R., Won C.H., Chung J.H., Cho K.H., Eun H.C., et al. Alteration of the TGF-beta/SMAD pathway in intrinsically and UV-induced skin aging. Mech Ageing Dev 2005, 126:560-567.
14. Yang G., Li Y., Nishimura E.K., Xin H., Zhou A., Guo Y., et al. Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol Cell 2008, 32:554-563.
15. Quan T., He T., Kang S., Voorhees J.J., Fisher G.J. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo. J Invest Dermatol 2002, 119:499-506.
16. Vijayachandra K., Lee J., Glick A.B. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res 2003, 63:3447-3452.
17. Glick A.B., Lee M.M., Darwiche N., Kulkarni A.B., Karlsson S., Yuspa S.H. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes Dev 1994, 8:2429-2440.
18. Sha W.C., Liou H.C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-kappaB leads to multifocal defects in immune responses. Cell 1995, 80:321-330.
19. Markell L.M., Masiuk K.E., Blazanin N., Glick A.B. Pharmacologic Inhibition of ALK5 Causes Selective Induction of Terminal Differentiation in Mouse Keratinocytes Expressing Oncogenic HRAS. Mol Cancer Res 2011.
20. Ha oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 1988, 48:165-169.
21. Hehner S.P., Heinrich M., Bork P.M., Vogt M., Ratter F., Lehmann V., et al. Sesquiterpene lactones specifically inhibit activation of NF-kappaB by preventing the degradation of I kappa B-alpha and I kappa B-beta. J Biol Chem 1998, 273:1288-1297.
22. Hehner S.P., Hofmann T.G., Droge W., Schmitz M.L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 1999, 163:5617-5623.
23. Metz M., Lammel V., Gibbs B.F., Maurer M. Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells. Am J Pathol 2006, 169:815-822.
24. Melnikova V.O., Pacifico A., Chimenti S., Peris K., Ananthaswamy H.N. Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development. Oncogene 2005, 24:7055-7063.
25. Saksela K., Baltimore D. Negative regulation of immunoglobulin kappa light-chain gene transcription by a short sequence homologous to the murine B1 repetitive element. Mol Cell Biol 1993, 13:3698-3705.
26. Bae D.S., Blazanin N., Licata M., Lee J., Glick A.B. Tumor suppressor and oncogene actions of TGFbeta1 occur early in skin carcinogenesis and are mediated by Smad3. Mol Carcinog 2009, 48:441-453.
27. Tong X., Yin L., Washington R., Rosenberg D.W., Giardina C. The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem 2004, 265:171-183.
28. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
29. Davis J.N., Kucuk O., Djuric Z., Sarkar F.H. Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes. Free Radical Biol Med 2001, 30:1293-1302.
30. Shan W., Nicol C.J., Ito S., Bility M.T., Kennett M.J., Ward J.M., et al. Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice. Hepatology 2008, 47:225-235.
31. Sakurai H., Miyoshi H., Toriumi W., Sugita T. Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J Biol Chem 1999, 274:10641-10648.
32. Kajino T., Omori E., Ishii S., Matsumoto K., Ninomiya-Tsuji J. TAK1 MAPK kinase kinase mediates transforming growth factor-beta signaling by targeting SnoN oncoprotein for degradation. J Biol Chem 2007, 282:9475-9481.
33. Broglie P., Matsumoto K., Akira S., Brautigan D.L., Ninomiya-Tsuji J. Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway. J Biol Chem 2010, 285:2333-2339.
34. Satterwhite T.S., Chong A.K., Luo J., Pham H., Costa M., Longaker M.T., et al. In vitro analysis of transforming growth factor-beta1 inhibition in novel transgenic SBE-luciferase mice. Ann Plast Surg 2007, 59:207-213.
35. Ruiz P.A., Shkoda A., Kim S.C., Sartor R.B., Haller D. IL-10 gene-deficient mice lack TGF-beta/Smad-mediated TLR2 degradation and fail to inhibit proinflammatory gene expression in intestinal epithelial cells under conditions of chronic inflammation. Ann NY Acad Sci 2006, 1072(389-94):389-394.
36. Matsukura S., Odaka M., Kurokawa M., Kuga H., Homma T., Takeuchi H., et al. Transforming growth factor-beta stimulates the expression of eotaxin/CC chemokine ligand 11 and its promoter activity through binding site for nuclear factor-kappaB in airway smooth muscle cells. Clin Exp Allergy 2010, 40:763-771.
37. Jana S., Jailwala P., Haribhai D., Waukau J., Glisic S., Grossman W., et al. The role of NF-kappaB and Smad3 in TGF-beta-mediated Foxp3 expression. Eur J Immunol 2009, 39:2571-2583.
38. Ishinaga H., Jono H., Lim J.H., Kweon S.M., Xu H., Ha U.H., et al. TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation. EMBO J 2007, 26:1150-1162.
39. Haller D., Holt L., Kim S.C., Schwabe R.F., Sartor R.B., Jobin C. Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. J Biol Chem 2003, 278:23851-23860.
40. Brandl M., Seidler B., Haller F., Adamski J., Schmid R.M., Saur D., et al. IKK(alpha) controls canonical TGF(ss)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells. J Cell Sci 2010, 123:4231-4239.
41. Maier H.J., Schmidt-Strassburger U., Huber M.A., Wiedemann E.M., Beug H., Wirth T. NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Lett 2010, 295:214-228.
42. Cohen J., Chen Z., Lu S.L., Yang X.P., Arun P., Ehsanian R., et al. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer. Cancer Res 2009, 69:3415-3424.
43. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Watanabe M., Kashiwagi K., et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 1999, 283:1317-1321.
44. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000, 19:1745-1754.
45. Kon A., Vindevoghel L., Kouba D.J., Fujimura Y., Uitto J., Mauviel A. Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression. Oncogene 1999, 18:1837-1844.
46. Shakhov A.N., Collart M.A., Vassalli P., Nedospasov S.A., Jongeneel C.V. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 1990, 171:35-47.
47. Collart M.A., Baeuerle P., Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 1990, 10:1498-1506.
48. Huang T.T., Kudo N., Yoshida M., Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci USA 2000, 97:1014-1019.
49. Bates PW, Miyamoto S. Expanded nuclear roles for IkappaBs. Sci STKE; 2004. p. e48.
50. Nottingham L.K., Yan C.H., Yang X., Si H., Coupar J., Bian Y., et al. Aberrant IKKalpha and IKKbeta cooperatively activate NF-kappaB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer. Oncogene 2013, 0:0.
51. Zhong H., May M.J., Jimi E., Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002, 9:625-636.
52. Guan H., Hou S., Ricciardi R.P. DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. J Biol Chem 2005, 280:9957-9962.
53. Salmeron A., Janzen J., Soneji Y., Bump N., Kamens J., Allen H., et al. Direct phosphorylation of NF-kappaB1 p105 by the IkappaB kinase complex on serine 927 is essential for signal-induced p105 proteolysis. J Biol Chem 2001, 276:22215-22222.
54. MacKichan M.L., Logeat F., Israel A. Phosphorylation of p105 PEST sequence via a redox-insensitive pathway up-regulates processing of p50 NF-kappaB. J Biol Chem 1996, 271:6084-6091.
55. Li C.C., Dai R.M., Chen E., Longo D.L. Phosphorylation of NF-KB1-p50 is involved in NF-kappa B activation and stable DNA binding. J Biol Chem 1994, 269:30089-30092.
56. Hou S., Guan H., Ricciardi R.P. Phosphorylation of serine 337 of NF-kappaB p50 is critical for DNA binding. J Biol Chem 2003, 278:45994-45998.
57. Viatour P., Merville M.P., Bours V., Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005, 30:43-52.
58. Fisher G.J., Datta S.C., Talwar H.S., Wang Z.Q., Varani J., Kang S., et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996, 379:335-339.
59. Chang E.J., Kundu J.K., Liu L., Shin J.W., Surh Y.J. Ultraviolet B radiation activates NF-kappaB and induces iNOS expression in HR-1 hairless mouse skin: role of IkappaB kinase-beta. Mol Carcinog 2011, 50:310-317.
60. Abeyama K., Eng W., Jester J.V., Vink A.A., Edelbaum D., Cockerell C.J., et al. A role for NF-kappaB-dependent gene transactivation in sunburn. J Clin Invest 2000, 105:1751-1759.
61. Afaq F., Adhami V.M., Ahmad N., Mukhtar H. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene 2003, 22:1035-1044.
62. Afaq F., Malik A., Syed D., Maes D., Matsui M.S., Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol 2005, 81:38-45.
63. Lewis D.A., Spandau D.F. UVB activation of NF-kappaB in normal human keratinocytes occurs via a unique mechanism. Arch Dermatol Res 2007, 299:93-101.
64. Strickland I., Rhodes L.E., Flanagan B.F., Friedmann P.S. TNF-alpha and IL-8 are upregulated in the epidermis of normal human skin after UVB exposure: correlation with neutrophil accumulation and E-selectin expression. J Invest Dermatol 1997, 108:763-768.
65. Bashir M.M., Sharma M.R., Werth V.P. UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol 2009, 129:994-1001.
66. Tobin D., van Hogerlinden M., Toftgard R. UVB-induced association of tumor necrosis factor (TNF) receptor 1/TNF receptor-associated factor-2 mediates activation of Rel proteins. Proc Natl Acad Sci USA 1998, 20(95):565-569.
67. Bazzoni F., Kruys V., Shakhov A., Jongeneel C.V., Beutler B. Analysis of tumor necrosis factor promoter responses to ultraviolet light. J Clin Invest 1994, 93:56-62.
68. Quan T., He T., Voorhees J.J., Fisher G.J. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. J Biol Chem 2001, 276:26349-26356.
69. Quan T., He T., Kang S., Voorhees J.J., Fisher G.J. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling. Am J Pathol 2004, 165:741-751.
70. Wang H., Kochevar I.E. Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes. Free Radical Biol Med 2005, 38:890-897.
71. Swamy M., Jamora C., Havran W., Hayday A. Epithelial decision makers: in search of the 'epimmunome'. Nat Immunol 2010, 11:656-665.
72. Perez-Lorenzo R., Markell L.M., Hogan K.A., Yuspa S.H., Glick A.B. Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis. Carcinogenesis 2010, 31:1116-1123.
73. Mordasky Markell L., Perez-Lorenzo R., Masiuk K.E., Kennett M.J., Glick A.B. Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression. Carcinogenesis 2010, 31:2127-2135.